Wigraine Side Effects

Generic name: caffeine / ergotamine

Medically reviewed by Drugs.com. Last updated on Aug 23, 2024.

Note: This document provides detailed information about Wigraine Side Effects associated with caffeine / ergotamine. Some dosage forms listed on this page may not apply specifically to the brand name Wigraine.

Applies to caffeine / ergotamine: oral tablet.

Other dosage forms:

• rectal suppository

Serious side effects of Wigraine

Along with its needed effects, caffeine/ergotamine may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.

Check with your doctor immediately if any of the following side effects occur while taking caffeine / ergotamine:

Incidence not known

• chest pain, discomfort, or tightness
• cold, pale, or a bluish color skin of the fingers or toes
• continuing loss of appetite
• continuing or severe nausea and vomiting
• continuing or severe stomach pain
• increased frequency of urination
• irregular heartbeat
• itching skin
• lower back pain
• numbness or tingling of the fingers or toes
• pain in the fingers or toes
• pain in arms legs, or lower back, especially pain in calves or heels upon exertion
• sweating
• swelling of hands, ankles, feet, or lower legs
• weakness
• weak or absent pulses in the legs

Get emergency help immediately if any of the following symptoms of overdose occur while taking caffeine / ergotamine:

Symptoms of overdose

• blurred vision
• change or loss of consciousness
• cold clammy skin
• decreased awareness or responsiveness
• dizziness, faintness, or lightheadedness when getting up suddenly from a lying or sitting position
• headache
• nervousness
• numbness, tingling, pain, and bluish color of the fingernails, lips, skin, palms, or nail beds
• pounding in the ears
• seizures
• severe sleepiness
• slow or fast heartbeat
• sweating
• unusual tiredness or weakness
• vomiting

Other side effects of Wigraine

Some side effects of caffeine / ergotamine may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.

Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:

Incidence not known

• burning, crawling, itching, numbness, prickling, "pins and needles", or tingling feelings
• dizziness or lightheadedness
• feeling of constant movement of self or surroundings
• sensation of spinning

For healthcare professionals

Applies to caffeine / ergotamine: oral tablet, rectal suppository.

General

The most commonly reported adverse effects have included nausea and vomiting.^[Ref]

Gastrointestinal

• Common (1% to 10%): Nausea, vomiting, abdominal pain
• Uncommon (0.1% to 1%): Diarrhea
• Frequency not reported: Retroperitoneal fibrosis^[Ref]

Nervous system

• Common (1% to 10%): Dizziness
• Uncommon (0.1% to 1%): Paraesthesia, hypoaesthesia
• Rare (less than 0.1%): Cerebral ischemia, drowsiness
• Frequency not reported: Weakness, somnolence, drug-induced headaches, withdrawal headaches^[Ref]

Reports of cerebral ischemia, including 1 death, have been reported for patients receiving ergotamine and protease inhibitors concomitantly. A black box warning is now required labeling for these drugs.

Drug-induced headaches have been reported during prolonged and uninterrupted use. Withdrawal headaches have been reported with discontinuation after prolonged use.^[Ref]

Cardiovascular

• Uncommon (0.1% to 1%): Peripheral vasoconstriction
• Rare (0.01% to 0.1%): Tachycardia, bradycardia, increased blood pressure
• Very rare (less than 0.01%): Myocardial ischemia, myocardial infarction, gangrene
• Frequency not reported: Ischemia, cyanosis, absence of pulse, cold extremities, precordial distress, EKG changes^[Ref]

Serious vasoconstrictive have occurred, more commonly with long-term therapy at relatively high doses, however, they have been reported with short-term or normal doses.^[Ref]

Respiratory

• Rare (Less than 0.1%): Dyspnea
• Frequency not reported: Pleuropulmonary fibrosis, fibrotic thickening of pulmonary valves

Musculoskeletal

• Uncommon (0.1% to 1%): Extremity pain
• Rare (Less than 0.1%): Myalgia^[Ref]

Hypersensitivity

• Rare (less than 0.1%): Rash, face edema, urticaria

Ocular

• Frequency not reported: Visual impairment
• Postmarketing reports: Loss of vision

Sudden and transient loss of vision have been reported, possibly due to vasospasm and ischemic episode.

Local

• Rare (less than 0.1%): Rectal or anal ulcer^[Ref]

Solitary rectal or anal ulcer have occurred, usually at higher than recommended doses or with continuous use for many years^[Ref]

Other

• Frequency not reported: Vertigo^[Ref]

Dermatologic

• Rare (Less than 0.1%): Rash, face edema, urticaria

Further information

Wigraine side effects can vary depending on the individual. Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Some side effects may not be reported. You may report them to the FDA.

Medical Disclaimer